These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
607 related articles for article (PubMed ID: 18200441)
1. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Srivastava DS; Mandhani A; Mittal RD Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. Mittal RD; Srivastava DL DNA Cell Biol; 2007 Nov; 26(11):791-8. PubMed ID: 17919073 [TBL] [Abstract][Full Text] [Related]
3. Association between lung cancer and microsomal epoxide hydrolase genotypes. Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050 [TBL] [Abstract][Full Text] [Related]
4. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803 [TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674 [TBL] [Abstract][Full Text] [Related]
7. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439 [TBL] [Abstract][Full Text] [Related]
8. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Xiao D; Wang C; Du MJ; Pang BS; Zhang HY; Xiao B; Liu JZ; Weng XZ; Su L; Christiani DC Chin Med J (Engl); 2004 May; 117(5):661-7. PubMed ID: 15161530 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365 [TBL] [Abstract][Full Text] [Related]
10. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Lin P; Wang SL; Wang HJ; Chen KW; Lee HS; Tsai KJ; Chen CY; Lee H Br J Cancer; 2000 Feb; 82(4):852-7. PubMed ID: 10732758 [TBL] [Abstract][Full Text] [Related]
11. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population. Pandey SN; Choudhuri G; Mittal B Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863 [TBL] [Abstract][Full Text] [Related]
12. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227 [TBL] [Abstract][Full Text] [Related]
13. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Srivastava DS; Kumar A; Mittal B; Mittal RD Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396 [TBL] [Abstract][Full Text] [Related]
17. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Brockmöller J; Cascorbi I; Kerb R; Roots I Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158 [TBL] [Abstract][Full Text] [Related]
18. CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Sam SS; Thomas V; Reddy SK; Surianarayanan G; Chandrasekaran A Head Neck; 2008 Dec; 30(12):1566-74. PubMed ID: 18767181 [TBL] [Abstract][Full Text] [Related]
19. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Srivastava DS; Mishra DK; Mandhani A; Mittal B; Kumar A; Mittal RD Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]